The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
miR-200–containing extracellular vesicles promote breast cancer cell metastasis
Open accessAbstract
Metastasis is associated with poor prognosis in breast cancer patients. Not all cancer cells within a tumor are capable of metastasizing. The microRNA-200 (miR-200) family, which regulates the mesenchymal-to-epithelial transition, is enriched in the serum of patients with metastatic cancers. Ectopic expression of miR-200 can confer metastatic ability to poorly metastatic tumor cells in some settings. Here, we investigated whether metastatic capability could be transferred between metastatic and nonmetastatic cancer cells via extracellular vesicles. miR-200 was secreted in extracellular vesicles from metastatic murine and human breast cancer cell lines, and miR-200 levels were increased in sera of mice bearing metastatic tumors. In culture, murine and human metastatic breast cancer cell extracellular vesicles transferred miR-200 microRNAs to nonmetastatic cells, altering gene expression and promoting mesenchymal-to-epithelial transition. In murine cancer and human xenograft models, miR-200-expressing tumors and extracellular vesicles from these tumors promoted metastasis of otherwise weakly metastatic cells either nearby or at distant sites and conferred to these cells the ability to colonize distant tissues in a miR-200-dependent manner. Together, our results demonstrate that metastatic capability can be transferred by the uptake of extracellular vesicles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedCirculating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272 · cited 1×
“This is accomplished in large part by inhibiting the expression of Zeb1 and Zeb2, transcriptional repressors of many epithelial genes (4).”
BackgroundAslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
Cheung, K. J., Gabrielson, E., Werb, Z., & Ewald, A. J. (2013) · Cell · doi:10.1016/j.cell.2013.11.029 · Cited by 833
Bobrie, A., Krumeich, S., Reyal, F., Recchi, C., Moita, L. F., Seabra, M. C., Ostrowski, M., & Théry, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0925 · Cited by 645
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
(1990) · PubMed · Cited by 612
Vanharanta, S., & Massagué, J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.007 · Cited by 563
Hur, K., Toiyama, Y., Takahashi, M., Balaguer, F., Nagasaka, T., Koike, J., Hemmi, H., Koi, M., Boland, C. R., & Goel, A. (2013) · Gut · doi:10.1136/gutjnl-2011-301846 · Cited by 533
Imagable 4T1 model for the study of late stage breast cancer
Tao, K., Fang, M., Alroy, J., & Sahagian, G. G. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-228 · Cited by 525
Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells
Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H., & Miller, F. R. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006461422273 · Cited by 408
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S., Han, H.-D., Shah, M. Y., Rodriguez-Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 402
miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases
Dykxhoorn, D. M., Wu, Y., Xie, H., Yu, F., Lal, A., Petrocca, F., Martinvalet, D., Song, E., Lim, B., & Lieberman, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007181 · Cited by 324
Self-citationTransformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes
Ince, T. A., Richardson, A. L., Bell, G. W., Saitoh, M., Godar, S., Karnoub, A. E., Iglehart, J. D., & Weinberg, R. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.013 · Cited by 309
Teplyuk, N. M., Mollenhauer, B., Gabriely, G., Giese, A., Kim, E., Smolsky, M., Kim, R. Y., Saria, M. G., Pastorino, S., Kesari, S., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos074 · Cited by 302
Toiyama, Y., Hur, K., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2014) · Annals of Surgery · doi:10.1097/sla.0b013e3182a6909d · Cited by 294
MicroRNA Expression Characterizes Oligometastasis(es)
Lussier, Y. A., Xing, H. R., Salama, J. K., Khodarev, N. N., Huang, Y., Zhang, Q., Khan, S. A., Yang, X., Hasselle, M. D., Darga, T. E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028650 · Cited by 281
Li, A., Omura, N., Hong, S.-M., Vincent, A., Walter, K., Griffith, M., Borges, M., & Goggins, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4227 · Cited by 272
Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1407 · Cited by 249
Tumor-cell-derived microvesicles as carriers of molecular information in cancer
Martins, V. R., Dias, M. S., & Hainaut, P. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835b7c81 · Cited by 211
Petrocca, F., Altschuler, G., Tan, S. M., Mendillo, M. L., Yan, H., Jerry, D. J., Kung, A. L., Hide, W., Ince, T. A., & Lieberman, J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.008 · Cited by 166
Self-citationMicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
Yu, S.-J., Hu, J.-Y., Kuang, X.-Y., Luo, J.-M., Hou, Y.-F., Di, G.-H., Wu, J., Shen, Z.-Z., Song, H.-Y., & Shao, Z.-M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1959 · Cited by 159
Paterson, E. L., Kazenwadel, J., Bert, A. G., Khew-Goodall, Y., Ruszkiewicz, A., & Goodall, G. J. (2013) · Neoplasia · doi:10.1593/neo.121828 · Cited by 158
Thomsen, K. G., Lyng, M., Lænkholm, A., Søkilde, R., Nielsen, B. S., Litman, T., & Ditzel, H. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1969-9 · Cited by 108
Recruitment of CD63 to Cryptococcus neoformans phagosomes requires acidification
Artavanis-Tsakonas, K., Love, J. C., Ploegh, H. L., & Vyas, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607528103 · Cited by 63
A potent 2′ -O- methylated RNA-based microRNA inhibitor with unique secondary structures
Haraguchi, T., Nakano, H., Tagawa, T., Ohki, T., Ueno, Y., Yoshida, T., & Iba, H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1317 · Cited by 53
Cited by
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
“The plasticity of cancer cells may also be attributed in part to exosomes, with exosomal miR-200 from metastatic breast cancer cells enhancing the epithelial to mesenchymal transition (EMT) andmetastasis of otherwiseweakly metastatic breast cancer cells (150).”
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444
The biology and function of exosomes in cancer
Kalluri, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81135 · Cited by 1,849
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363
Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study
Zaborowski, M. P., Balaj, L., Breakefield, X. O., & Lai, C. P. (2015) · BioScience · doi:10.1093/biosci/biv084 · Cited by 1,268
Self-citation
Metadata
- Authors
- Le, M. T. N., Hamar, P., Guo, C., Basar, E., Perdigão-Henriques, R., Balaj, L., & Lieberman, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-11-17
- Volume
- 124
- Issue
- 12
- Pages
- 5109-5128
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2099676867
- Cited by
- 449
- References
- 29
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.